Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae
The Journal of Pharmacology and Experimental Therapeutics · 2024
DOI: 10.1124/jpet.122.001253 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Pharmacology and Experimental Therapeutics, 2024. Verfasst von Pasquale Mone und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Resear…. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus, MicroRNAs, Hypertension. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Emerging evidence indicates that the relationship between coronavirus disease 2019 (COVID-19) and diabetes is 2-fold: 1) it is known that the presence of diabetes and other metabolic alterations poses a considerably high risk to develop a severe COVID-19; 2) patients who survived a severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection have an increased risk of developing new-onset diabetes. However, the mechanisms underlying this association are mostly unknown, and there are no reliable biomarkers to predict the development of new-onset diabetes. In the present study, we demonstrate that a specific microRNA (miR-34a) contained in circulating extracellular vesicles released by endothelial cells reliably predicts the risk of developing new-onset diabetes in COVID-19. This association was independent of age, sex, body mass index (BMI), hypertension, dyslipidemia, smoking status, and D-dimer. SIGNIFICANCE STATEMENT: We demonstrate for the first time that a specific microRNA (miR-34a) contained in circulating extracellular vesicles released by endothelial cells is able to reliably predict the risk of developing diabetes after having contracted coronavirus disease 2019 (COVID-19). This association was independent of age, sex, body mass index (BMI), hypertension, dyslipidemia, smoking status, and D-dimer. Our findings are also relevant when considering the emerging importance of post-acute sequelae of COVID-19, with systemic manifestations observed even months after viral negativization (long COVID).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Einstein-Sinai Diabetes Research Center, Fleischer Institute for Diabetes and Metabolism, Einstein Institute for Aging Research (P.M., S.S.J., J.G., U.K., A.L., F.V., G.S.) and Department of Mole…
ORCID-Profile: Pasquale Mone, Urna Kansakar, Gaetano Santulli
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Mone, P., Jankauskas, S. S., Manzi, M. V., Gambardella, J., Coppola, A., Kansakar, U., Izzo, R., Fiorentino, G., Lombardi, A., Varzideh, F., Sorriento, D., Trimarco, B., & Santulli, G. (2024). Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1124/jpet.122.001253
Vancouver
Mone P, Jankauskas SS, Manzi MV, Gambardella J, Coppola A, Kansakar U, et al. Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae. The Journal of Pharmacology and Experimental Therapeutics. 2024. doi:10.1124/jpet.122.001253
BibTeX
@article{Mone2024,
author = {Mone, Pasquale and Jankauskas, Stanislovas S and Manzi, Maria Virginia and Gambardella, Jessica and Coppola, Antonietta and Kansakar, Urna and Izzo, Raffaele and Fiorentino, Giuseppe and Lombardi, Angela and Varzideh, Fahimeh and Sorriento, Daniela and Trimarco, Bruno and Santulli, Gaetano},
title = {Endothelial Extracellular Vesicles Enriched in microRNA-34a Predict New-Onset Diabetes in Coronavirus Disease 2019 (COVID-19) Patients: Novel Insights for Long COVID Metabolic Sequelae},
journal = {The Journal of Pharmacology and Experimental Therapeutics},
year = {2024},
doi = {10.1124/jpet.122.001253}
}
EUVIMED